These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32782570)

  • 41. Knockdown of CENPU inhibits cervical cancer cell migration and stemness through the FOXM1/Wnt/β-catenin pathway.
    Zhang X; Wang M; Zhang Y; Yang J; Duan W
    Tissue Cell; 2023 Apr; 81():102009. PubMed ID: 36608638
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genistein attenuates cancer stem cell characteristics in gastric cancer through the downregulation of Gli1.
    Yu D; Shin HS; Lee YS; Lee D; Kim S; Lee YC
    Oncol Rep; 2014 Feb; 31(2):673-8. PubMed ID: 24297371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. FOXM1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and mediates sensitivity to cisplatin in A549 cells via the JNK/mitochondrial pathway.
    Liu Y; Chen X; Gu Y; Zhu L; Qian Y; Pei D; Zhang W; Shu Y
    Neoplasma; 2015; 62(1):61-71. PubMed ID: 25563368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-216b suppresses cell proliferation, migration, invasion, and epithelial-mesenchymal transition by regulating FOXM1 expression in human non-small cell lung cancer.
    Wang L; Wang Y; Du X; Yao Y; Wang L; Jia Y
    Onco Targets Ther; 2019; 12():2999-3009. PubMed ID: 31114243
    [No Abstract]   [Full Text] [Related]  

  • 45. FOXM1 promotes the progression of non-small cell lung cancer by inhibiting miR-509-5p expression via binding to the miR-509-5p promoter region.
    Tian M; Li J; Wu H; Wu Y
    Heliyon; 2024 Mar; 10(5):e27147. PubMed ID: 38495135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells.
    Wen Q; Xu C; Zhou J; Liu NM; Cui YH; Quan MF; Cao JG; Ren KQ
    BMC Cancer; 2019 Mar; 19(1):224. PubMed ID: 30866863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma.
    Luo W; Gao F; Li S; Liu L
    Front Oncol; 2018; 8():483. PubMed ID: 30416986
    [No Abstract]   [Full Text] [Related]  

  • 48. Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic.
    Liu Y; Hock JM; Van Beneden RJ; Li X
    Mol Carcinog; 2014 May; 53(5):380-91. PubMed ID: 23255470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer.
    Kong FF; Qu ZQ; Yuan HH; Wang JY; Zhao M; Guo YH; Shi J; Gong XD; Zhu YL; Liu F; Zhang WY; Jiang B
    Oncol Rep; 2014 Jun; 31(6):2660-8. PubMed ID: 24715097
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FoxM1 is a novel target of a natural agent in pancreatic cancer.
    Wang Z; Ahmad A; Banerjee S; Azmi A; Kong D; Li Y; Sarkar FH
    Pharm Res; 2010 Jun; 27(6):1159-68. PubMed ID: 20354770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. BTB and CNC homology 1 (Bach1) induces lung cancer stem cell phenotypes by stimulating CD44 expression.
    Jiang P; Li F; Liu Z; Hao S; Gao J; Li S
    Respir Res; 2021 Dec; 22(1):320. PubMed ID: 34949193
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The expression and function of PD-L1 in CD133(+) human liver cancer stem-like cells].
    Bai YD; Shi ML; Li SQ; Wang XL; Peng JJ; Zhou DJ; Sun FF; Li H; Wang C; Du M; Zhang T; Li D
    Zhonghua Zhong Liu Za Zhi; 2023 Feb; 45(2):117-128. PubMed ID: 36781232
    [No Abstract]   [Full Text] [Related]  

  • 53. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
    Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
    Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Knockdown of FOXM1 suppresses cell growth and metastasis in human laryngeal cancer via the AKT signaling pathway.
    Yan J; Hou J; Yan Y; Ren XY; Luo HN; Wang ZG; Zheng GX
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6786-6793. PubMed ID: 32633370
    [TBL] [Abstract][Full Text] [Related]  

  • 55. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 56. Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro.
    Wu QF; Liu C; Tai MH; Liu D; Lei L; Wang RT; Tian M; Lü Y
    Acta Pharmacol Sin; 2010 Mar; 31(3):361-6. PubMed ID: 20154714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
    Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
    J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer.
    He SY; Shen HW; Xu L; Zhao XH; Yuan L; Niu G; You ZS; Yao SZ
    Gynecol Oncol; 2012 Dec; 127(3):601-10. PubMed ID: 22943878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
    Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
    [TBL] [Abstract][Full Text] [Related]  

  • 60. RND3 Transcriptionally Regulated by FOXM1 Inhibits the Migration and Inflammation of Synovial Fibroblasts in Rheumatoid Arthritis Through the Rho/ROCK Pathway.
    Dai L; Chen X; Zhang H; Zeng H; Yin Z; Ye Z; Wei Y
    J Interferon Cytokine Res; 2022 Jun; 42(6):279-289. PubMed ID: 35699481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.